1. Home
  2. AURE vs MYO Comparison

AURE vs MYO Comparison

Compare AURE & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prestige Wealth Inc. Class A Ordinary Shares

AURE

Prestige Wealth Inc. Class A Ordinary Shares

BUY

Current Price

$1.75

Market Cap

65.4M

Sector

Finance

ML Signal

BUY

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.49

Market Cap

68.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AURE
MYO
Founded
2018
2004
Country
Hong Kong
United States
Employees
4
N/A
Industry
Finance: Consumer Services
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.4M
68.9M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
AURE
MYO
Price
$1.75
$1.49
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
11.4K
722.8K
Earning Date
06-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,000,000,000.00
Revenue This Year
N/A
$9.10
Revenue Next Year
N/A
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$0.18
$0.61
52 Week High
$3.53
$1.89

Technical Indicators

Market Signals
Indicator
AURE
MYO
Relative Strength Index (RSI) N/A 52.85
Support Level N/A $0.77
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.21
MACD 0.00 -0.00
Stochastic Oscillator 0.00 52.02

Price Performance

Historical Comparison
AURE
MYO

About AURE Prestige Wealth Inc. Class A Ordinary Shares

Aurelion Inc is a Tether Gold (XAUT) Real World Asset (RWA) company focused on developing a business around tokenized gold. XAUT combines the stability of physical gold with the efficiency of blockchain, providing investors access to a tokenized gold reserve that could serve as a haven to inflation, currency devaluation, and crypto volatility. In parallel to building a business around the development of tokenized gold, Aurelion provides wealth management and asset management services.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: